Maponga CC - Search Results

1

Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program.

Mudzviti T, Sibanda M, Gavi S, Maponga CC, Morse GD. Mudzviti T, et al. Among authors: maponga cc. J Infect Dev Ctries. 2012 Nov 26;6(11):806-8. doi: 10.3855/jidc.1908. J Infect Dev Ctries. 2012. PMID: 23277506 Free PMC article.

2

HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries.

Maponga CC, Ma Q, Slish JC, Morse GD. Maponga CC, et al. Top HIV Med. 2007 Jun-Jul;15(3):104-10. Top HIV Med. 2007. PMID: 17598930 Review.

3

Moringa oleifera leaf extracts inhibit 6beta-hydroxylation of testosterone by CYP3A4.

Monera TG, Wolfe AR, Maponga CC, Benet LZ, Guglielmo J. Monera TG, et al. Among authors: maponga cc. J Infect Dev Ctries. 2008 Oct 1;2(5):379-83. doi: 10.3855/jidc.201. J Infect Dev Ctries. 2008. PMID: 19745507 Free PMC article.

4

The impact of herbal remedies on adverse effects and quality of life in HIV-infected individuals on antiretroviral therapy.

Bepe N, Madanhi N, Mudzviti T, Gavi S, Maponga CC, Morse GD. Bepe N, et al. Among authors: maponga cc. J Infect Dev Ctries. 2011 Feb 1;5(1):48-53. doi: 10.3855/jidc.1415. J Infect Dev Ctries. 2011. PMID: 21330740 Free PMC article.

5

The impact of herbal drug use on adverse drug reaction profiles of patients on antiretroviral therapy in zimbabwe.

Mudzviti T, Maponga CC, Khoza S, Ma Q, Morse GD. Mudzviti T, et al. Among authors: maponga cc. AIDS Res Treat. 2012;2012:434171. doi: 10.1155/2012/434171. Epub 2012 Mar 19. AIDS Res Treat. 2012. PMID: 22506106 Free PMC article.

6

Global HIV/AIDS Clinical and Translational Pharmacology.

Morse GD, Maartens G, Maponga CC, Ma Q. Morse GD, et al. Among authors: maponga cc. AIDS Res Treat. 2012;2012:973627. doi: 10.1155/2012/973627. Epub 2012 Jul 18. AIDS Res Treat. 2012. PMID: 22852073 Free PMC article. No abstract available.

7

Multimodal nanoparticles that provide immunomodulation and intracellular drug delivery for infectious diseases.

Dube A, Reynolds JL, Law WC, Maponga CC, Prasad PN, Morse GD. Dube A, et al. Among authors: maponga cc. Nanomedicine. 2014 May;10(4):831-8. doi: 10.1016/j.nano.2013.11.012. Epub 2013 Dec 10. Nanomedicine. 2014. PMID: 24333593

8

Poly(lactic-co-glycolic) Acid-Chitosan Dual Loaded Nanoparticles for Antiretroviral Nanoformulations.

Makita-Chingombe F, Kutscher HL, DiTursi SL, Morse GD, Maponga CC. Makita-Chingombe F, et al. Among authors: maponga cc. J Drug Deliv. 2016;2016:3810175. doi: 10.1155/2016/3810175. Epub 2016 Apr 17. J Drug Deliv. 2016. PMID: 27190651 Free PMC article.

9

Quality and labeling information of Moringa oleifera products marketed for HIV-infected people in Zimbabwe.

Monera-Penduka TG, Jani ZT, Maponga CC, Mudzengi J, Morse GD, Nhachi CF. Monera-Penduka TG, et al. Among authors: maponga cc. J Public Health Afr. 2016 Dec 31;7(2):84-88. doi: 10.4081/jphia.2016.618. J Public Health Afr. 2016. PMID: 28239441 Free PMC article.

10

Capacity for ethical and regulatory review of herbal trials in developing countries: a case study of Moringa oleifera research in HIV-infected patients.

Monera-Penduka TG, Maponga CC, Morse GD, Nhachi CFB. Monera-Penduka TG, et al. Among authors: maponga cc. J Pharm Policy Pract. 2017 Feb 20;10:9. doi: 10.1186/s40545-017-0099-5. eCollection 2017. J Pharm Policy Pract. 2017. PMID: 28250958 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters